Ceftaroline fosamil acetate
| Title | Journal |
|---|---|
| Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection. | Antimicrobial agents and chemotherapy 20130601 |
| Summary of ceftaroline fosamil clinical trial studies and clinical safety. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120901 |
| Early response of ceftaroline fosamic in the treatment of soft-tissue infections. | Expert review of clinical pharmacology 20120901 |
| Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. | Drugs 20120730 |
| Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus. | Clinical therapeutics 20120401 |
| New drugs 2012 part I. | Nursing 20120301 |
| Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies. | PloS one 20120101 |
| Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111115 |
| Ceftaroline (Teflaro): a new cephalosporin. | The Nurse practitioner 20111101 |
| Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. | The Annals of pharmacotherapy 20111101 |
| Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy. | Expert review of anti-infective therapy 20110801 |
| Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus. | The Journal of antimicrobial chemotherapy 20110401 |
| Ceftaroline fosamil: a new broad-spectrum cephalosporin. | The Journal of antimicrobial chemotherapy 20110401 |
| FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. | The Journal of antimicrobial chemotherapy 20110401 |
| FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. | The Journal of antimicrobial chemotherapy 20110401 |
| Review of ceftaroline fosamil microbiology: integrated FOCUS studies. | The Journal of antimicrobial chemotherapy 20110401 |
| Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia. | The Journal of antimicrobial chemotherapy 20110401 |
| What are the properties that make an antibiotic acceptable for therapy of community-acquired pneumonia? | The Journal of antimicrobial chemotherapy 20110401 |
| Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil. Preface. | The Journal of antimicrobial chemotherapy 20110401 |
| Ceftaroline fosamil (Teflaro) - a new IV cephalosporin. | The Medical letter on drugs and therapeutics 20110124 |
| Ceftaroline fosamil: drug profile and clinical data. | Future microbiology 20110101 |
| New drugs: Ceftaroline fosamil, pegloticase, and eribulin mesylate. | Journal of the American Pharmacists Association : JAPhA 20110101 |
| [Ceftaroline fosamil, a broad spectrum cephalosporin antibiotic for the treatment of community-acquired pneumonia and complicated skin and skin structure infections]. | Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20110101 |
| Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101215 |
| The problem of complicated skin and skin structure infections: the need for new agents. | The Journal of antimicrobial chemotherapy 20101101 |
| Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity. | The Journal of antimicrobial chemotherapy 20101101 |
| CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. | The Journal of antimicrobial chemotherapy 20101101 |
| CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. | The Journal of antimicrobial chemotherapy 20101101 |
| Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. | The Journal of antimicrobial chemotherapy 20101101 |
| Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity. | The Journal of antimicrobial chemotherapy 20101101 |
| Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model. | The Journal of antimicrobial chemotherapy 20101001 |
| Ceftaroline fosamil: a novel broad-spectrum cephalosporin. | Drugs of today (Barcelona, Spain : 1998) 20101001 |
| Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens. | Pharmacotherapy 20100401 |
| Stability and stabilization studies of TAK-599 (Ceftaroline Fosamil), a novel N-phosphono type prodrug of anti-methicillin resistant Staphylococcus aureus cephalosporin T-91825. | Chemical & pharmaceutical bulletin 20081001 |
| Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection. | Current opinion in investigational drugs (London, England : 2000) 20080201 |